| 英文别名 |
2H-1-Benzopyran-3,5,7-triol,2-(3,4-dihydroxyphenyl)-3,4-dihydro-, hydrate (1:1), (2R,3S)-;Catechin hydrate;DL-CATECHIN;2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, monohydrate, (2R,3S)- (9CI);2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, monohydrate, (2R-trans)- (ZCI);(+)-Catechin hydrate;(+)-Catechin monohydrate;TCI-C 0958;(2R,3S)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol;(+)-Cyanidol-3;AKOS016843747;W-104471;trans-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol;CHEMBL1256783;S00276;SCHEMBL133974;2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, monohydrate, (2R-trans)-;SMR000326724;88191-48-4;(+)-Catechin hydrate, >=96.0% (sum of enantiomers, HPLC);(2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol hydrate;MFCD00149354;2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol monohydrate, (2R-trans)-;(+/-)-Catechin hydrate, primary pharmaceutical reference standard;(+)-Catechin xhydrate;OFUMQWOJBVNKLR-NQQJLSKUSA-N;(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol;hydrate;DS-2787;2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, monohydrate, (2R,3S)-;(+)-Catechin hydrate, >=98% (HPLC), powder;D-Catechin hydrate;trans-3,3',4',5,7-Pentahydroxyflavane;CHEBI:58994;(+/-)-Catechin hydrate, purum, >=96.0% (HPLC);SR-01000075742-11;(+/-)-Catechin (hydrate);(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol hydrate;(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol monohydrate;Q27126384;(2R,3S)-2-(3,4-Dihydroxyphenyl)-chroman-3,5,7-triol hydrate;Cianidanol (JAN/INN);D00200;(2R,3S)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol--water (1/1);(+)-catechinhydrate;MFCD00150865;HMS3649E10;(+)-3,3',4',5,7-Flavanpentol . H2O;MLS001056745;SR-01000075742-15;225937-10-0;DTXSID801007988;HMS2233I24 |